WHY SHOULD YOU BE INTERESTED IN FINANCING?
Funding is a crucial point to guarantee access to the gene and cell therapies market and thus the availability of French patients. However, the major innovation they represent requires an in-depth review of our health system. Indeed, the added value of these therapies is the prospect of treating illnesses that were previously incurable in a single administration. However, their development entails very high costs with which it will be necessary to deal in particular to ensure the sustainability of their coverage by health insurance.
Determining the funding opportunities for R&D projects linked to the gene and cell therapy environment is a major challenge for G & CTI. The mission of the "financing" group will be to answer an essential question: how to generate an effective investment throughout the development cycle of these therapies? The first step defined by the group to answer this question is to identify public or private funds capable of supporting disruptive innovation in health.